Preparation of amyloid beta-protein for structural and functional studies (Q46201444)

20 December 2017

title

Preparation of amyloid beta-protein for structural and functional studies (English)

1 reference

20 December 2017

author name string

David B Teplow

series ordinal

1

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

20 December 2017

published in

Methods in Enzymology

1 reference

20 December 2017

volume

413

1 reference

20 December 2017

page(s)

20-33

1 reference

20 December 2017

Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Supramolecular structure in full-length Alzheimer's beta-amyloid fibrils: evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Diseases of protein conformation: what do in vitro experiments tell us about in vivo diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Fourier transform infrared spectroscopic investigation of temperature- and pressure-induced disaggregation of amyloid A

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Aggregation State and Neurotoxic Properties of Alzheimer Beta-Amyloid Peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid β-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Abeta protofibrils possess a stable core structure resistant to hydrogen exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Soluble multimeric Alzheimer beta(1-40) pre-amyloid complexes in dilute solution.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Alzheimer's beta-peptide oligomer formation at physiologic concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Monitoring protein assembly using quasielastic light scattering spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Conformational dynamics of amyloid beta-protein assembly probed using intrinsic fluorescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Properties and possible significance of substance P and insulin fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. Comparative analyses of nine amyloid preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

The Toxicity of the Alzheimer's β-Amyloid Peptide Correlates with a Distinct Fiber Morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Solvent effects on self-assembly of beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Reconstitution of amyloid fibrils from alkaline extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Spontaneous Aggregation and Cytotoxicity of the β-Amyloid Aβ1–40: A Kinetic Model

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Structural and kinetic features of amyloid beta-protein fibrillogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Emerging ideas on the molecular basis of protein and peptide aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Progress towards a molecular-level structural understanding of amyloid fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Deciphering the molecular basis of memory failure in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2913002-5

7 January 2021

10.1016/S0076-6879(06)13002-5

Identifiers

DOI

1 reference

20 December 2017

release_6txoylg2xze6xbk7soyqqpskui

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6txoylg2xze6xbk7soyqqpskui

24 November 2022

mapped directly with Wikidata item

1 reference

20 December 2017